The Chinese IP office knocked out several claims from the sole patent owned by the NPE that was deemed essential and infringed in a recent Nanjing FRAND ruling
Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases
Intellectual property systems are becoming more complex and that makes law schools’ one-size-fits all approach looks increasingly out of date, says Franklin Pierce dean
Read more
After deal for cellular chip business with Apple, the company places rest of the assets that were on the market in the summer back on the auction block
Read more
In sales due to be held this month and next, the Korean company offers two radically different portfolios. But value is in the eye of the beholder - and a range of businesses could be making bids
Read more
IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value
Read more
As IAM releases this year's brokered patent market survey one of its authors digs deep into the current climate for transactions and explains why some of the grunt work of five years ago is a thing of the past
Read more
Acquirer out of Taiwan says transaction will broaden its IP portfolio and add significant R&D resources, but it is not clear just how many patents will change hands
Read more
Over the weekend, Novartis struck one of the largest deals in the biopharma sectors this year, agreeing to pay $9.7 billion for cardiovascular specialist The Medicines Company
Read more
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.
